A global panel of pundits discussed how can emerging technologies like AI, Big Data, Robotics, IoT, and Biotechnology help us fight today’s and tomorrow’s pandemics. Our panelists will include a cross-section of experts and practitioners across multiple disciplines. During our one-hour discussion, we explored what the pundits have to say about combating this pandemic. What tools and technologies are currently at their disposal? What new solutions do they believe need to be developed? Can human ingenuity and innovation help us put pandora back in the box?

2. Gargi B. Dasgupta is the Director for IBM Research in India and the CTO for IBM
India/South Asia. In her role as Director, Gargi is responsible for establishing and
executing the technical agenda of IBM's India Research Lab in collaboration with IBM's
worldwide research labs and business units.
• In her role as CTO, Gargi is responsible for representing and communicating IBM's
overall technical vision & strategy with key stakeholders across the India/South Asia
ecosystem – from developers and start-ups to key clients, analysts, media, and
industry experts
• Prior to this role Gargi was the senior manager at IBM Research-India leading the
work in AI for Automation driving both deep technology innovations and real
impact into IBM's enterprise solutions
• Gargi serves as a strategist for IBM Research, working closely with IBM's Hybrid
Cloud business and global services businesses to take innovative solutions to
clients across the globe. She helped establish new research directions at the
intersection of service science, text analytics, and AI. Gargi has been with IBM since
2004 when she joined as a Research Staff Member. Gargi is an ACM Distinguished
Speaker and an alumni of University of Maryland, Baltimore County
DR. GARGI BANERJEE DASGUPTA
DIRECTOR, IBM RESEARCH
(INDIA)
CTO, IBM INDIA AND SOUTH
ASIA
You wear two hats at IBM – Director, IBM Research and CTO for IBM in
India and South Asia, how are those roles complimentary and how are
they different?

3. A deep technology entrepreneur delivering value in the most challenging
environments on earth. Mike designs IoT devices for materials analysis using
Photonic technology.
• Has designed and delivered novel, cost effective technical solutions
including 2 generations of wireless internet cameras, full software
test/development infrastructures, HAZMAT mobile command center for
Port of Seattle first responders, world's first parking garage car counting
solution utilizing video analytics, Raman spectrographic analysis of
biomaterials and more
• Mike provides strategic guidance to C-level decision makers. He serves
with multiple public agencies focusing on analysis and review of large
deep technology projects
• A strong supporter of the deep technology community, Mike is active in
mentoring startups via Hackathons
MIKE RICHARDSON
MANAGING DIRECTOR
PHOTONIC INSIGHTS
What is unique and special about the technologies that Photonic Insights is
developing? What is your definition of deep tech and why do you believe
that it is the need of the hour?

4. Mahi de Silva is a technologist, serial entrepreneur, advisor and investor in
technology. He is currently CEO and co-founder of marketing-tech company
Amplify.ai an artificial intelligence (AI) and natural language processing company
that aims to help businesses interact with their customers via AI-powered
chatbots.
• Worked at Apple in the “Pink” System Software Group from as a “Pointillist”
• Was a part of the startup team at VeriSign, roles included Vice President (VP)
- Engineering and the General Manager (GM) of the Wireless business
• Former CEO of Frengo Corporation
• Co-Founded AdMarvel Inc., a company aimed at improving the efficiency of
the mobile advertising marketplace. Purchased by Opera in 2010. Mahi was
SVP of Consumer Mobile for Opera Software ASA and was CEO of Opera
Mediaworks
• Chairman of the Board at Noventis, Inc.
• Board Member at Nanotech Energy Inc, SuperMetalix Inc., and Hydrophilix,
Inc.
• In 2013, Mahi was named number #12 on a list of the 29 most important
people in mobile advertising.
MAHI DE SILVA
CO-FOUNDER & CEO
AMPLIFY.AI
What is conversational AI and how is Amplify’s technology different or
similar to IBM’s Watson?

5. An entrepreneur and expert in E-health and the software industry, Klas is particularly
interested in helping ”startups” get to the next level. As a Senior Advisor, he builds the
organization, grows the business and helps raise capital. He usually takes an active
role in the beginning as an interim in various roles such as Advisor, CEO, VP or Board
Member.
• More than 30 years of experience in Healthcare with 20 years in e-health.
• Former VP iZafe
• Former CEO of FRISQ
• Multiple Roles @ Cambio Software Engineering including Liaison Officer Sri Lanka
(18+ Years)
• Chairman of the Board: Mendly, DoktorHemma, PictureMyLife, and Transfer Jobb
• Board Member: Dots Solutions
• Owner & Founder: Wineflight Sweden
• Pioneered MRI protocols for Sweden at Magnetkameran MRAB
• MRI Technician/Registered Nurse
KLAS ARVIDSON
CEO
RAYTELLIGENCE
What do you believe to be the greatest challenge posed by this pandemic on the
healthcare systems you helped develop? What can we as technologists and
entrepreneurs do to meet that challenge?

6. Experienced business and technology executive with a demonstrated history in the
enterprise software and medical device industry.
• Advisor to Steth IO and former CEO
• Co-Founder, Chairman and CTO of Winshuttle – He propelled the company’s
technology strategy to support enterprise, workflow and mobile solutions,
helping thousands of customers maximize their investments in enterprise
applications such as SAP ERP, Oracle EBS and Salesforce.com.
• Prior to Winshuttle, Vikram spent several years in the software industry
concentrating on data mining and business intelligence applications.
• His previous positions included engineering leadership positions at Verathon,Inc.
and Insightful Software (now part of Tibco Corp)
• Advisor Medimetry
• Vikram is a published author of more than 20 journal articles and holds more
than a dozen US and international patents.
DR VIKRAM CHALANA
CEO
PICTORY CORP
At Verathon, where you were Director of R&D, and at Steth IO where
you were the CEO, you were instrumental in developing ground-
breaking medical devices. In your opinion, what is the single biggest
challenge in getting life saving medical devices to market? Do you see
that impediment diminishing or increasing post this pandemic?

7. •Asymptomatic
•Symptomatic
General
Population
•Negative
•Positive
Detection:
Testing •Self-Isolation
•Quarantine
•Contact Tracing
Observation
•Cured
•Recovered
•Terminal
Hospitalization
PANDEMIC LIFECYCLE
EARLY DETECTION & ISOLATION IS KEY
VACCINE CURE

8. 01
06 03
02
0405
HEALTHCARE PROVIDERS
Doctors, Nurses, Orderlies,
Administrators
POLICE & MILITARY
Law & Order
National Security
SCIENTISTS/RESEARCHERS
Experts Working on
Solutions
FRONTLINE WORKERS
Essential Services
Personnel
GENERAL POPULATION
Asymptomatic
Self-Isolating/Quarantine
Hospitalized
Recovered/Immune
GOVERNMENT OFFICIALS
Local, State &
Federal/Central
Government Agencies
HEALTHCARE PROVIDERS
GENERAL POPULATION
SCIENTISTS, RESEARCHERS & TECHNOLOGISTS
POLICE & MILITARY
GOVERNMENT OFFICIALS
FRONTLINE WORKERS
PANDEMIC STAKEHOLDERS
NEW HEROS FOR A NEW VILLIAN

9. PANDEMIC TECHNOLOGY LANDSCAPE
E X I S T I N G & E M E R G I N G P A N D E M I C T E C H N O L O G I E S
DIAGNOSTICS
• Rapid Test
• Antibody Test
• Gene Test (Crispr)
• Saliva Test
CONTACT TRACING
• Apple & Google
Privacy Preserving
Open Source
• Individual Country
Apps
SELF-ISOLATION
QUARANTINE
LOCKDOWN
COMPLIANCE
• Cameras
• Drones
• Geo-Fenced
Wristbands (Hong
Kong)
SELF CARE
• Telemedicine
• RPM (EaZense)
• StethIO
• Pulse, Blood
Pressure, Blood
Sugar, Weight, Sleep,
Activity Trackers
• Clinical Decision
Support
HOSPITALIZATION
• Medical Devices
(Ventilators, CPAP,
etc.)
• PPEs
• Robots
• Tele-Consult
• EMR/HMS
• Clinical Trials
THERAPUETICS
• Research (AI, ML &
Big Data)
• Symptom Mitigation
• Treatment Protocols
• Cure(s)
• Vaccines/Immunizati
on
CRISIS COMMUNICATION
COMMUNITY CORPERATION
• Mobile Apps (News,
Alerts, Updates,
Notifications)
• Chat Bots

10. https://www.sonnets-project.eu/content/blog-post-5-emerging-technologies-and-their-application-public-sector-0
EMERGING TECH HYPE CYCLE 2017

17. https://mspoweruser.com/singapore-is-open-sourcing-their-tracetogether-covid-19-app/

18. CAPABILITIES
1. Provide extreme granular and near real-time geo-
analytic insights
2. Enrich density insights with Customer 360 information
based on real behaviors & interests
3. Allow for location comparison to conduct analysis
between two locations
4. Flexible analysis capabilities with simple and easy to
use dashboard interface
is a market insights solution that uses unique & highly precise location-based insights
on consumer density, with ability to cross reference with our cutting-edge consumer
profile, product interest segments, and other Big Data insights.

19. PANDEMIC TECH – SELF CARE
DR. VIKRAM CHALANA

20. PANDEMIC TECHNOLOGY EXAMPLES
DR. VIKRAM CHALANA
• Epidemiological Modelling and Analytics
• Contact Tracing
• Remote Patient Monitoring & Telemedicine
• Surrogate Biomarkers

21. PANDEMIC TECH – CRISIS COMMUNICATION
MAHI DE SILVA

23. PANDEMIC TECH – REMOTE PATIENT MONITORING
KLAS ARVIDSON

24. CPHNANO (DENMARK)
SOLUTION: THIS DANISH STARTUP IS USING THEIR TECHNOLOGY TO DEVELOP AND PRODUCE
AN AFFORDABLE DIAGNOSTIC SALIVA TEST FOR COVID-19.
DETECTION

25. CHRONOMICS (UK)
SOLUTION: CHRONOMICS HAVE DEVELOPED AN RT-PCR TEST FOR THE VIRUS, READY TO SCALE
TO POPULATION LEVEL.
DETECTION

26. DARWINAI (CANADA)
SOLUTION: THIS CANADIAN STARTUP CO-STARTED AN OPEN-SOURCE AI TOOL TO HELP DETECT
THE VIRUS VIA X-RAY ANALYSIS.
DETECTION

27. SENTINEL BIOSENSOR (UK)
SOLUTION: THEIR AI-POWERED VITAL-SIGNS SENSOR, C-DETECT DEVICE, CAN DETECT IF THE
PATIENT IS GOING TO FULLY DEVELOP COVID-19 AND SUBSEQUENTLY IF THEIR SITUATION IS
GOING TO DETERIORATE OR IF THEY ARE STABLE.
DETECTION

28. SENTINEL BIOSENSOR (UK)
SOLUTION: THEIR HANDHELD DEVICE, CARDIOSPIRE, IS ABLE TO OBTAIN CLINICAL GRADE DATA
STREAMS FROM A PATIENT IN A REMOTE SETTING INCLUDING SPIROMETRY AND LUNG
SOUNDS.
DETECTION

29. VIDCARE INNOVATIONS (INDIA)
SOLUTION: THEY HAVE STARTED WORK ON A NEW MEDICAL TESTING DEVICE BASED ON THEIR
EXISTING KNOW-HOW ON SURVEILLANCE OF DISEASES TO PREVENT SPREAD DURING OUTBREAKS.
THE DEVICE IS AN EQUIPMENT-FREE, EASY-TO-USE MICROFLUIDICS-BASED IMMUNOASSAY DEVICE
FOR MULTI-ANALYTE DETECTION OF INFECTIONS.
DETECTION

30. IKTOS (FRANCE)
SOLUTION: THIS FRENCH STARTUP HAS TEAMED UP WITH SRI TO DEVELOP A SYNTHETIC
CHEMISTRY PLATFORM TO DISCOVER NEW COMPOUNDS AGAINST CORONAVIRUS MORE QUICKLY.
DRUG DISCOVERY

31. MACROMOLTEK (USA)
SOLUTION: THIS AMERICAN-BASED STARTUP IS WORKING ON A COMPUTATIONAL DESIGN OF A
NOVEL ANTIBODY DRUG FOR COVID-19.
DRUG DISCOVERY

32. MOLECULE.ONE (POLAND)
SOLUTION: THIS POLISH STARTUP IS GRANTING FREE ACCESS TO THEIR SERVICE THAT ENABLES
CHEMISTS TO QUICKLY IDENTIFY WHICH OF THE POTENTIAL MEDICINES FOR COVID-19 ARE THE
MOST ACCESSIBLE.
DRUG DISCOVERY

33. GALACTICA BIOTECH (IRELAND)
SOLUTION: THIS IRISH STARTUP IS APPLYING THEIR DEEP LEARNING PLATFORM TO IDENTIFY ANTI-
COVID-19 MOLECULES BY SCREENING SEVERAL TYPES OF LIBRARIES.
DRUG DISCOVERY

34. ASTROPRINT (USA)
SOLUTION: THIS STARTUP IS LEADING A NEW INITIATIVE, THEY HAVE RELEASED AN APP TO
SUPPORT CROWD-SOURCED 3D PRINTING EFFORTS TO HELP PRODUCE VITAL MATERIALS SUCH AS
FACE SHIELDS OR EVEN VENTILATORS.
SUPPORT SYSTEMS

35. GEOTWIN (FRANCE)
SOLUTION: AN AI-BASED DECISION-MAKING PLATFORM THAT SIMULATES THE BEHAVIOUR OF
INDIVIDUALS. FED BY ANONYMIZED SOCIO-DEMOGRAPHIC AND MOBILE PHONE DATA, IT CAN
REPRESENT AND BETTER UNDERSTAND THE EFFECTS OF CONTAINMENT MEASURES AND CITY
MOBILITY PATTERNS BEFORE AND AFTER COVID-19.
SUPPORT SYSTEMS

36. OPTICSURG (USA)
SOLUTION: THEIR MIXED REALITY TELEHEALTH PLATFORM CAN POTENTIALLY BRIDGE THE GAPS IN
CARE DELIVERY AND ALSO HELP PRESERVE FRONTLINE CAPACITY.
SUPPORT SYSTEMS

37. ATLANT 3D NANOSYTEMS (DENMARK)
SOLUTION: A UNIQUE MICROFLUIDIC TECHNOLOGY FOR THEIR 3D PRINTHEAD DESIGN, WHICH CAN
BENEFIT THE DESIGN OF RAPID COVID TESTING SOLUTIONS AND IMMUNITY TESTING.
SUPPORT SYSTEMS

38. BE SURE HEALTHCARE (NETHERLANDS)
SOLUTION: WITH THEIR PARTNERS PRECISE AND SENCEBAND, THEY HAVE ADOPTED THEIR AI AND BIOFEEDBACK-
BASED SOLUTIONS TO RESPOND TO THE NEEDS OF PATIENTS AND CAREGIVERS DURING COVID-19, OFFERING
SOLUTIONS FOR PATIENT MONITORING AND CLINICAL DECISION SUPPORT.
SUPPORT SYSTEMS

39. Q & A
DISCOVER | DEBATE | DEBUNK